Sun Pharma gets ANDA approval
Sun Pharma gets ANDA approval

Sun Pharma gets ANDA approval

Dnyanada Kulkarni Article rating: 5.0

India’s top pharma company, Sun Pharma received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for the generic version of Generic Ganirelix Acetate injection, 250 mcg/0.5 ml.

 

SC verdict revives Rcom; up 9 per cent
SC verdict revives Rcom; up 9 per cent

SC verdict revives Rcom; up 9 per cent

Gayathri Udyawar Article rating: 5.0

The stock of Reliance Telecommunication (Rcom) spiked up in the early morning session on Monday, reacting to the Supreme Court order that allows the company to go ahead with the spectrum sale after ensuring a corporate guarantee from Reliance Realty.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 74.64 lakhs contracts with a turnover of Rs. 4,39,239.97 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 3.8

Overall volumes in futures & options currently stand at 74.64 lakhs contracts with a turnover of Rs. 4,39,239.97 crore.

Index trend and stocks in action December 03, 2018
Index trend and stocks in action December 03, 2018

Index trend and stocks in action December 03, 2018

Karan Dsij Article rating: 5.0

In the coming session, Nifty has an immediate resistance around the level of 10,920 and a follow-through move above this level may take Nifty towards its 100-day moving average, i.e. 10,958. Stocks in news: Sun Pharma Advanced Research (SPARC), Biocon, Laurus Labs, Monte Carlo Fashions, BHEL, Genus Paper and Boards, Ashiana Housing, M&M Fin, VIP Clothing and Cadila Healthcare.

Gap-up opening likely as global cues are positive
Gap-up opening likely as global cues are positive

Gap-up opening likely as global cues are positive

Karan Dsij Article rating: 5.0

Indian benchmark indices are likely to open with a gap-up largely in tandem with the firm trend in other Asian bourses as investors cheered the news that Donald Trump and Xi Jinping have agreed to a temporary truce on the trade war. On Friday, the GDP data released after market hours  indicated that the Indian economy growth slowed to 7.1 per cent in the September quarter. Auto stocks will be in focus today as companies released monthly sales figures over the weekend.  The SGX Nifty Index Future was trading higher by 73 points at 10,983.

Zydus Cadila receives USFDA nod for Teriflunomide Tablets
Zydus Cadila receives USFDA nod for Teriflunomide Tablets

Zydus Cadila receives USFDA nod for Teriflunomide Tablets

Shohini Nath Article rating: 5.0

Zydus Cadila has received the final approval for Teriflunomide tablets from the United States of Food and Drug Association (USFDA). Shares of the company could most likely be in limelight on Monday’s trading session.

IDBI, Bollinger Band Squeeze pick
IDBI, Bollinger Band Squeeze pick

IDBI, Bollinger Band Squeeze pick

Vinayak Gangule Article rating: 4.5

IDBI bounced almost 30 per cent from its previous support zone and then it has been trading in a narrow contracting trading range since early October. This stock recently occurred in our Bollinger Band Squeeze scanner which suggests that consolidation breakout is near.

SBIN: Contracting Triangle in progress
SBIN: Contracting Triangle in progress

SBIN: Contracting Triangle in progress

Vinayak Gangule Article rating: 5.0

A triangle forms when the price action narrows over several price swings. In SBIN, on the daily scale, the contracting triangle is in progress for the last four weeks. The price has reached near the apex point of the contracting triangle, next week it is likely to give a breakout.

RBI relieves NBFCs while helping realty
RBI relieves NBFCs while helping realty

RBI relieves NBFCs while helping realty

Gayathri Udyawar Article rating: 5.0

The apex bank has allowed NBFCs to securitise loans of more than 5-year maturity if the loans were held for over six months on their books. This relaxation will provide extra liquidity to the NBFC sector.

RSS
First31253126312731283130313231333134Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR